BWC 0977
Alternative Names: BWC-0977Latest Information Update: 28 Nov 2024
Price :
$50 *
At a glance
- Originator BUGWORKS Research
- Class 2 ring heterocyclic compounds; Antibacterials; Ethylamines; Fluorinated hydrocarbons; Ketones; Oxazines; Pyrazines; Quinolines; Small molecules
- Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Bacterial infections
Most Recent Events
- 28 Nov 2024 No recent reports of development identified for phase-I development in Bacterial-infections(In volunteers) in Australia (IV, Infusion)
- 13 Jun 2024 Pharmacodynamics data from a preclinical studies in bacterial infections presented at the ASM Microbe 2024 (ASM-2024)
- 12 Apr 2024 Chemical structure information added